nodes	percent_of_prediction	percent_of_DWPC	metapath
Tolazamide—Alcohol intolerance—Efavirenz—acquired immunodeficiency syndrome	0.0299	0.0307	CcSEcCtD
Tolazamide—Alcohol intolerance—Delavirdine—acquired immunodeficiency syndrome	0.0286	0.0294	CcSEcCtD
Tolazamide—Alcohol intolerance—Ritonavir—acquired immunodeficiency syndrome	0.0264	0.0272	CcSEcCtD
Tolazamide—Eruption—Efavirenz—acquired immunodeficiency syndrome	0.0154	0.0159	CcSEcCtD
Tolazamide—Heartburn—Saquinavir—acquired immunodeficiency syndrome	0.0117	0.0121	CcSEcCtD
Tolazamide—Aplastic anaemia—Abacavir—acquired immunodeficiency syndrome	0.0115	0.0118	CcSEcCtD
Tolazamide—Hypoglycaemia—Didanosine—acquired immunodeficiency syndrome	0.0106	0.011	CcSEcCtD
Tolazamide—Aplastic anaemia—Zidovudine—acquired immunodeficiency syndrome	0.0101	0.0104	CcSEcCtD
Tolazamide—Jaundice cholestatic—Ritonavir—acquired immunodeficiency syndrome	0.00956	0.00984	CcSEcCtD
Tolazamide—Hypoglycaemia—Nelfinavir—acquired immunodeficiency syndrome	0.00927	0.00954	CcSEcCtD
Tolazamide—Haemolytic anaemia—Zidovudine—acquired immunodeficiency syndrome	0.00869	0.00894	CcSEcCtD
Tolazamide—Haemolytic anaemia—Indinavir—acquired immunodeficiency syndrome	0.00808	0.00831	CcSEcCtD
Tolazamide—Abdominal distension—Nelfinavir—acquired immunodeficiency syndrome	0.00787	0.0081	CcSEcCtD
Tolazamide—Agranulocytosis—Didanosine—acquired immunodeficiency syndrome	0.00747	0.00769	CcSEcCtD
Tolazamide—Haemolytic anaemia—Delavirdine—acquired immunodeficiency syndrome	0.0073	0.00752	CcSEcCtD
Tolazamide—Aplastic anaemia—Lamivudine—acquired immunodeficiency syndrome	0.00724	0.00745	CcSEcCtD
Tolazamide—Agranulocytosis—Nevirapine—acquired immunodeficiency syndrome	0.00672	0.00692	CcSEcCtD
Tolazamide—Hyponatraemia—Delavirdine—acquired immunodeficiency syndrome	0.00662	0.00681	CcSEcCtD
Tolazamide—Haemolytic anaemia—Saquinavir—acquired immunodeficiency syndrome	0.0065	0.00669	CcSEcCtD
Tolazamide—Pancytopenia—Zidovudine—acquired immunodeficiency syndrome	0.00644	0.00662	CcSEcCtD
Tolazamide—Abdominal distension—Indinavir—acquired immunodeficiency syndrome	0.00635	0.00653	CcSEcCtD
Tolazamide—Hypoglycaemia—Saquinavir—acquired immunodeficiency syndrome	0.00601	0.00619	CcSEcCtD
Tolazamide—Abdominal distension—Efavirenz—acquired immunodeficiency syndrome	0.006	0.00617	CcSEcCtD
Tolazamide—Hyponatraemia—Saquinavir—acquired immunodeficiency syndrome	0.00589	0.00606	CcSEcCtD
Tolazamide—Discomfort—Amprenavir—acquired immunodeficiency syndrome	0.00577	0.00594	CcSEcCtD
Tolazamide—Abdominal distension—Delavirdine—acquired immunodeficiency syndrome	0.00574	0.0059	CcSEcCtD
Tolazamide—Hypoglycaemia—Lamivudine—acquired immunodeficiency syndrome	0.00574	0.0059	CcSEcCtD
Tolazamide—Pancytopenia—Efavirenz—acquired immunodeficiency syndrome	0.00566	0.00582	CcSEcCtD
Tolazamide—Malaise—Didanosine—acquired immunodeficiency syndrome	0.00564	0.00581	CcSEcCtD
Tolazamide—Agranulocytosis—Zidovudine—acquired immunodeficiency syndrome	0.00564	0.0058	CcSEcCtD
Tolazamide—Erythema—Nevirapine—acquired immunodeficiency syndrome	0.00563	0.00579	CcSEcCtD
Tolazamide—Leukopenia—Didanosine—acquired immunodeficiency syndrome	0.0056	0.00577	CcSEcCtD
Tolazamide—Erythema—Nelfinavir—acquired immunodeficiency syndrome	0.00545	0.00561	CcSEcCtD
Tolazamide—Photosensitivity reaction—Efavirenz—acquired immunodeficiency syndrome	0.00544	0.00559	CcSEcCtD
Tolazamide—Pancytopenia—Delavirdine—acquired immunodeficiency syndrome	0.00541	0.00557	CcSEcCtD
Tolazamide—Abdominal distension—Ritonavir—acquired immunodeficiency syndrome	0.0053	0.00546	CcSEcCtD
Tolazamide—Discomfort—Didanosine—acquired immunodeficiency syndrome	0.00526	0.00542	CcSEcCtD
Tolazamide—Ill-defined disorder—Nevirapine—acquired immunodeficiency syndrome	0.00522	0.00537	CcSEcCtD
Tolazamide—Abdominal distension—Saquinavir—acquired immunodeficiency syndrome	0.00511	0.00526	CcSEcCtD
Tolazamide—Malaise—Nevirapine—acquired immunodeficiency syndrome	0.00507	0.00522	CcSEcCtD
Tolazamide—Ill-defined disorder—Nelfinavir—acquired immunodeficiency syndrome	0.00506	0.0052	CcSEcCtD
Tolazamide—Thrombocytopenia—Didanosine—acquired immunodeficiency syndrome	0.005	0.00515	CcSEcCtD
Tolazamide—Ill-defined disorder—Abacavir—acquired immunodeficiency syndrome	0.00497	0.00511	CcSEcCtD
Tolazamide—Malaise—Nelfinavir—acquired immunodeficiency syndrome	0.00491	0.00506	CcSEcCtD
Tolazamide—Leukopenia—Nelfinavir—acquired immunodeficiency syndrome	0.00488	0.00502	CcSEcCtD
Tolazamide—Abdominal distension—Lamivudine—acquired immunodeficiency syndrome	0.00487	0.00501	CcSEcCtD
Tolazamide—Leukopenia—Stavudine—acquired immunodeficiency syndrome	0.00486	0.00501	CcSEcCtD
Tolazamide—Gastrointestinal disorder—Amprenavir—acquired immunodeficiency syndrome	0.00484	0.00498	CcSEcCtD
Tolazamide—Fatigue—Amprenavir—acquired immunodeficiency syndrome	0.00483	0.00497	CcSEcCtD
Tolazamide—Malaise—Abacavir—acquired immunodeficiency syndrome	0.00483	0.00497	CcSEcCtD
Tolazamide—Pancytopenia—Saquinavir—acquired immunodeficiency syndrome	0.00482	0.00496	CcSEcCtD
Tolazamide—Photosensitivity reaction—Ritonavir—acquired immunodeficiency syndrome	0.00481	0.00495	CcSEcCtD
Tolazamide—Vertigo—Abacavir—acquired immunodeficiency syndrome	0.00481	0.00495	CcSEcCtD
Tolazamide—Leukopenia—Abacavir—acquired immunodeficiency syndrome	0.00479	0.00493	CcSEcCtD
Tolazamide—Discomfort—Nevirapine—acquired immunodeficiency syndrome	0.00473	0.00487	CcSEcCtD
Tolazamide—Erythema—Zidovudine—acquired immunodeficiency syndrome	0.00472	0.00486	CcSEcCtD
Tolazamide—Photosensitivity reaction—Saquinavir—acquired immunodeficiency syndrome	0.00463	0.00476	CcSEcCtD
Tolazamide—Pancytopenia—Lamivudine—acquired immunodeficiency syndrome	0.00459	0.00473	CcSEcCtD
Tolazamide—Discomfort—Nelfinavir—acquired immunodeficiency syndrome	0.00458	0.00472	CcSEcCtD
Tolazamide—Discomfort—Abacavir—acquired immunodeficiency syndrome	0.0045	0.00463	CcSEcCtD
Tolazamide—Thrombocytopenia—Nevirapine—acquired immunodeficiency syndrome	0.0045	0.00463	CcSEcCtD
Tolazamide—Dyspepsia—Didanosine—acquired immunodeficiency syndrome	0.0045	0.00463	CcSEcCtD
Tolazamide—Ill-defined disorder—Zidovudine—acquired immunodeficiency syndrome	0.00438	0.00451	CcSEcCtD
Tolazamide—Thrombocytopenia—Nelfinavir—acquired immunodeficiency syndrome	0.00436	0.00448	CcSEcCtD
Tolazamide—Thrombocytopenia—Stavudine—acquired immunodeficiency syndrome	0.00434	0.00447	CcSEcCtD
Tolazamide—Thrombocytopenia—Abacavir—acquired immunodeficiency syndrome	0.00428	0.0044	CcSEcCtD
Tolazamide—Malaise—Zidovudine—acquired immunodeficiency syndrome	0.00426	0.00438	CcSEcCtD
Tolazamide—Vertigo—Zidovudine—acquired immunodeficiency syndrome	0.00424	0.00437	CcSEcCtD
Tolazamide—Leukopenia—Zidovudine—acquired immunodeficiency syndrome	0.00423	0.00435	CcSEcCtD
Tolazamide—Erythema—Efavirenz—acquired immunodeficiency syndrome	0.00415	0.00427	CcSEcCtD
Tolazamide—Ill-defined disorder—Indinavir—acquired immunodeficiency syndrome	0.00408	0.00419	CcSEcCtD
Tolazamide—Agranulocytosis—Lamivudine—acquired immunodeficiency syndrome	0.00403	0.00414	CcSEcCtD
Tolazamide—Asthenia—Amprenavir—acquired immunodeficiency syndrome	0.00402	0.00414	CcSEcCtD
Tolazamide—Discomfort—Zidovudine—acquired immunodeficiency syndrome	0.00397	0.00409	CcSEcCtD
Tolazamide—Erythema—Delavirdine—acquired immunodeficiency syndrome	0.00397	0.00409	CcSEcCtD
Tolazamide—Gastrointestinal disorder—Nevirapine—acquired immunodeficiency syndrome	0.00397	0.00408	CcSEcCtD
Tolazamide—Pruritus—Amprenavir—acquired immunodeficiency syndrome	0.00396	0.00408	CcSEcCtD
Tolazamide—Malaise—Indinavir—acquired immunodeficiency syndrome	0.00396	0.00408	CcSEcCtD
Tolazamide—Fatigue—Nevirapine—acquired immunodeficiency syndrome	0.00396	0.00408	CcSEcCtD
Tolazamide—Vertigo—Indinavir—acquired immunodeficiency syndrome	0.00395	0.00406	CcSEcCtD
Tolazamide—Dyspepsia—Nelfinavir—acquired immunodeficiency syndrome	0.00392	0.00403	CcSEcCtD
Tolazamide—Dyspepsia—Stavudine—acquired immunodeficiency syndrome	0.0039	0.00402	CcSEcCtD
Tolazamide—Ill-defined disorder—Efavirenz—acquired immunodeficiency syndrome	0.00385	0.00396	CcSEcCtD
Tolazamide—Gastrointestinal disorder—Nelfinavir—acquired immunodeficiency syndrome	0.00384	0.00395	CcSEcCtD
Tolazamide—Gastrointestinal disorder—Stavudine—acquired immunodeficiency syndrome	0.00383	0.00394	CcSEcCtD
Tolazamide—Fatigue—Stavudine—acquired immunodeficiency syndrome	0.00382	0.00393	CcSEcCtD
Tolazamide—Feeling abnormal—Nevirapine—acquired immunodeficiency syndrome	0.00378	0.0039	CcSEcCtD
Tolazamide—Thrombocytopenia—Zidovudine—acquired immunodeficiency syndrome	0.00377	0.00388	CcSEcCtD
Tolazamide—Gastrointestinal disorder—Abacavir—acquired immunodeficiency syndrome	0.00377	0.00388	CcSEcCtD
Tolazamide—Fatigue—Abacavir—acquired immunodeficiency syndrome	0.00377	0.00388	CcSEcCtD
Tolazamide—Malaise—Efavirenz—acquired immunodeficiency syndrome	0.00374	0.00385	CcSEcCtD
Tolazamide—Vertigo—Efavirenz—acquired immunodeficiency syndrome	0.00373	0.00384	CcSEcCtD
Tolazamide—Discomfort—Indinavir—acquired immunodeficiency syndrome	0.00369	0.0038	CcSEcCtD
Tolazamide—Ill-defined disorder—Delavirdine—acquired immunodeficiency syndrome	0.00368	0.00379	CcSEcCtD
Tolazamide—Feeling abnormal—Nelfinavir—acquired immunodeficiency syndrome	0.00367	0.00377	CcSEcCtD
Tolazamide—Asthenia—Didanosine—acquired immunodeficiency syndrome	0.00366	0.00377	CcSEcCtD
Tolazamide—Urticaria—Nevirapine—acquired immunodeficiency syndrome	0.00365	0.00376	CcSEcCtD
Tolazamide—Pruritus—Didanosine—acquired immunodeficiency syndrome	0.00361	0.00372	CcSEcCtD
Tolazamide—Feeling abnormal—Abacavir—acquired immunodeficiency syndrome	0.0036	0.00371	CcSEcCtD
Tolazamide—Malaise—Delavirdine—acquired immunodeficiency syndrome	0.00358	0.00369	CcSEcCtD
Tolazamide—Vertigo—Delavirdine—acquired immunodeficiency syndrome	0.00357	0.00367	CcSEcCtD
Tolazamide—Leukopenia—Delavirdine—acquired immunodeficiency syndrome	0.00355	0.00366	CcSEcCtD
Tolazamide—Erythema—Saquinavir—acquired immunodeficiency syndrome	0.00353	0.00364	CcSEcCtD
Tolazamide—Urticaria—Nelfinavir—acquired immunodeficiency syndrome	0.00353	0.00364	CcSEcCtD
Tolazamide—Rash—Amprenavir—acquired immunodeficiency syndrome	0.00353	0.00364	CcSEcCtD
Tolazamide—Urticaria—Stavudine—acquired immunodeficiency syndrome	0.00352	0.00363	CcSEcCtD
Tolazamide—Headache—Amprenavir—acquired immunodeficiency syndrome	0.00351	0.00361	CcSEcCtD
Tolazamide—Thrombocytopenia—Indinavir—acquired immunodeficiency syndrome	0.00351	0.00361	CcSEcCtD
Tolazamide—Discomfort—Efavirenz—acquired immunodeficiency syndrome	0.00349	0.00359	CcSEcCtD
Tolazamide—Urticaria—Abacavir—acquired immunodeficiency syndrome	0.00347	0.00357	CcSEcCtD
Tolazamide—Ill-defined disorder—Ritonavir—acquired immunodeficiency syndrome	0.00341	0.00351	CcSEcCtD
Tolazamide—Dyspepsia—Zidovudine—acquired immunodeficiency syndrome	0.00339	0.00349	CcSEcCtD
Tolazamide—Erythema—Lamivudine—acquired immunodeficiency syndrome	0.00337	0.00347	CcSEcCtD
Tolazamide—Discomfort—Delavirdine—acquired immunodeficiency syndrome	0.00334	0.00344	CcSEcCtD
Tolazamide—Nausea—Amprenavir—acquired immunodeficiency syndrome	0.00333	0.00343	CcSEcCtD
Tolazamide—Gastrointestinal disorder—Zidovudine—acquired immunodeficiency syndrome	0.00333	0.00342	CcSEcCtD
Tolazamide—Fatigue—Zidovudine—acquired immunodeficiency syndrome	0.00332	0.00342	CcSEcCtD
Tolazamide—Thrombocytopenia—Efavirenz—acquired immunodeficiency syndrome	0.00332	0.00341	CcSEcCtD
Tolazamide—Malaise—Ritonavir—acquired immunodeficiency syndrome	0.00331	0.00341	CcSEcCtD
Tolazamide—Vertigo—Ritonavir—acquired immunodeficiency syndrome	0.0033	0.0034	CcSEcCtD
Tolazamide—Asthenia—Nevirapine—acquired immunodeficiency syndrome	0.0033	0.00339	CcSEcCtD
Tolazamide—Leukopenia—Ritonavir—acquired immunodeficiency syndrome	0.00329	0.00338	CcSEcCtD
Tolazamide—Ill-defined disorder—Saquinavir—acquired immunodeficiency syndrome	0.00328	0.00337	CcSEcCtD
Tolazamide—Pruritus—Nevirapine—acquired immunodeficiency syndrome	0.00325	0.00334	CcSEcCtD
Tolazamide—Rash—Didanosine—acquired immunodeficiency syndrome	0.00322	0.00331	CcSEcCtD
Tolazamide—Headache—Didanosine—acquired immunodeficiency syndrome	0.0032	0.00329	CcSEcCtD
Tolazamide—Asthenia—Nelfinavir—acquired immunodeficiency syndrome	0.00319	0.00328	CcSEcCtD
Tolazamide—Malaise—Saquinavir—acquired immunodeficiency syndrome	0.00319	0.00328	CcSEcCtD
Tolazamide—Asthenia—Stavudine—acquired immunodeficiency syndrome	0.00318	0.00327	CcSEcCtD
Tolazamide—Feeling abnormal—Zidovudine—acquired immunodeficiency syndrome	0.00318	0.00327	CcSEcCtD
Tolazamide—Vertigo—Saquinavir—acquired immunodeficiency syndrome	0.00317	0.00327	CcSEcCtD
Tolazamide—Thrombocytopenia—Delavirdine—acquired immunodeficiency syndrome	0.00317	0.00327	CcSEcCtD
Tolazamide—Leukopenia—Saquinavir—acquired immunodeficiency syndrome	0.00316	0.00326	CcSEcCtD
Tolazamide—Dyspepsia—Indinavir—acquired immunodeficiency syndrome	0.00316	0.00325	CcSEcCtD
Tolazamide—Pruritus—Nelfinavir—acquired immunodeficiency syndrome	0.00315	0.00324	CcSEcCtD
Tolazamide—Pruritus—Stavudine—acquired immunodeficiency syndrome	0.00314	0.00323	CcSEcCtD
Tolazamide—Asthenia—Abacavir—acquired immunodeficiency syndrome	0.00313	0.00323	CcSEcCtD
Tolazamide—Ill-defined disorder—Lamivudine—acquired immunodeficiency syndrome	0.00313	0.00322	CcSEcCtD
Tolazamide—Gastrointestinal disorder—Indinavir—acquired immunodeficiency syndrome	0.00309	0.00319	CcSEcCtD
Tolazamide—Pruritus—Abacavir—acquired immunodeficiency syndrome	0.00309	0.00318	CcSEcCtD
Tolazamide—Fatigue—Indinavir—acquired immunodeficiency syndrome	0.00309	0.00318	CcSEcCtD
Tolazamide—Discomfort—Ritonavir—acquired immunodeficiency syndrome	0.00309	0.00318	CcSEcCtD
Tolazamide—Urticaria—Zidovudine—acquired immunodeficiency syndrome	0.00306	0.00315	CcSEcCtD
Tolazamide—Gliclazide—ALB—acquired immunodeficiency syndrome	0.00306	0.656	CrCbGaD
Tolazamide—Malaise—Lamivudine—acquired immunodeficiency syndrome	0.00304	0.00313	CcSEcCtD
Tolazamide—KCNJ1—nervous system—acquired immunodeficiency syndrome	0.00304	0.128	CbGeAlD
Tolazamide—Nausea—Didanosine—acquired immunodeficiency syndrome	0.00303	0.00312	CcSEcCtD
Tolazamide—Vertigo—Lamivudine—acquired immunodeficiency syndrome	0.00303	0.00312	CcSEcCtD
Tolazamide—Leukopenia—Lamivudine—acquired immunodeficiency syndrome	0.00302	0.00311	CcSEcCtD
Tolazamide—Dyspepsia—Efavirenz—acquired immunodeficiency syndrome	0.00298	0.00307	CcSEcCtD
Tolazamide—Discomfort—Saquinavir—acquired immunodeficiency syndrome	0.00297	0.00306	CcSEcCtD
Tolazamide—Feeling abnormal—Indinavir—acquired immunodeficiency syndrome	0.00295	0.00304	CcSEcCtD
Tolazamide—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	0.00294	0.00303	CcSEcCtD
Tolazamide—Thrombocytopenia—Ritonavir—acquired immunodeficiency syndrome	0.00293	0.00302	CcSEcCtD
Tolazamide—Dizziness—Stavudine—acquired immunodeficiency syndrome	0.00293	0.00302	CcSEcCtD
Tolazamide—KCNJ1—central nervous system—acquired immunodeficiency syndrome	0.00293	0.123	CbGeAlD
Tolazamide—Gastrointestinal disorder—Efavirenz—acquired immunodeficiency syndrome	0.00292	0.00301	CcSEcCtD
Tolazamide—Fatigue—Efavirenz—acquired immunodeficiency syndrome	0.00292	0.00301	CcSEcCtD
Tolazamide—Rash—Nevirapine—acquired immunodeficiency syndrome	0.0029	0.00298	CcSEcCtD
Tolazamide—Dizziness—Abacavir—acquired immunodeficiency syndrome	0.00289	0.00297	CcSEcCtD
Tolazamide—Headache—Nevirapine—acquired immunodeficiency syndrome	0.00288	0.00296	CcSEcCtD
Tolazamide—Dyspepsia—Delavirdine—acquired immunodeficiency syndrome	0.00285	0.00294	CcSEcCtD
Tolazamide—Urticaria—Indinavir—acquired immunodeficiency syndrome	0.00285	0.00293	CcSEcCtD
Tolazamide—Discomfort—Lamivudine—acquired immunodeficiency syndrome	0.00284	0.00292	CcSEcCtD
Tolazamide—Thrombocytopenia—Saquinavir—acquired immunodeficiency syndrome	0.00282	0.00291	CcSEcCtD
Tolazamide—Rash—Nelfinavir—acquired immunodeficiency syndrome	0.0028	0.00289	CcSEcCtD
Tolazamide—Gastrointestinal disorder—Delavirdine—acquired immunodeficiency syndrome	0.0028	0.00288	CcSEcCtD
Tolazamide—Rash—Stavudine—acquired immunodeficiency syndrome	0.0028	0.00288	CcSEcCtD
Tolazamide—Fatigue—Delavirdine—acquired immunodeficiency syndrome	0.00279	0.00288	CcSEcCtD
Tolazamide—Feeling abnormal—Efavirenz—acquired immunodeficiency syndrome	0.00279	0.00287	CcSEcCtD
Tolazamide—Headache—Nelfinavir—acquired immunodeficiency syndrome	0.00279	0.00287	CcSEcCtD
Tolazamide—Headache—Stavudine—acquired immunodeficiency syndrome	0.00278	0.00286	CcSEcCtD
Tolazamide—Asthenia—Zidovudine—acquired immunodeficiency syndrome	0.00277	0.00285	CcSEcCtD
Tolazamide—Rash—Abacavir—acquired immunodeficiency syndrome	0.00275	0.00283	CcSEcCtD
Tolazamide—Headache—Abacavir—acquired immunodeficiency syndrome	0.00274	0.00282	CcSEcCtD
Tolazamide—Nausea—Nevirapine—acquired immunodeficiency syndrome	0.00273	0.00281	CcSEcCtD
Tolazamide—Pruritus—Zidovudine—acquired immunodeficiency syndrome	0.00273	0.00281	CcSEcCtD
Tolazamide—Thrombocytopenia—Lamivudine—acquired immunodeficiency syndrome	0.00269	0.00277	CcSEcCtD
Tolazamide—Urticaria—Efavirenz—acquired immunodeficiency syndrome	0.00269	0.00277	CcSEcCtD
Tolazamide—Feeling abnormal—Delavirdine—acquired immunodeficiency syndrome	0.00267	0.00275	CcSEcCtD
Tolazamide—Nausea—Nelfinavir—acquired immunodeficiency syndrome	0.00264	0.00272	CcSEcCtD
Tolazamide—Dyspepsia—Ritonavir—acquired immunodeficiency syndrome	0.00264	0.00271	CcSEcCtD
Tolazamide—Nausea—Stavudine—acquired immunodeficiency syndrome	0.00263	0.00271	CcSEcCtD
Tolazamide—Nausea—Abacavir—acquired immunodeficiency syndrome	0.00259	0.00267	CcSEcCtD
Tolazamide—Gastrointestinal disorder—Ritonavir—acquired immunodeficiency syndrome	0.00259	0.00266	CcSEcCtD
Tolazamide—Fatigue—Ritonavir—acquired immunodeficiency syndrome	0.00258	0.00266	CcSEcCtD
Tolazamide—Urticaria—Delavirdine—acquired immunodeficiency syndrome	0.00257	0.00265	CcSEcCtD
Tolazamide—Asthenia—Indinavir—acquired immunodeficiency syndrome	0.00257	0.00265	CcSEcCtD
Tolazamide—Dizziness—Zidovudine—acquired immunodeficiency syndrome	0.00255	0.00262	CcSEcCtD
Tolazamide—Dyspepsia—Saquinavir—acquired immunodeficiency syndrome	0.00254	0.00261	CcSEcCtD
Tolazamide—Pruritus—Indinavir—acquired immunodeficiency syndrome	0.00254	0.00261	CcSEcCtD
Tolazamide—Gastrointestinal disorder—Saquinavir—acquired immunodeficiency syndrome	0.00249	0.00256	CcSEcCtD
Tolazamide—Fatigue—Saquinavir—acquired immunodeficiency syndrome	0.00249	0.00256	CcSEcCtD
Tolazamide—Feeling abnormal—Ritonavir—acquired immunodeficiency syndrome	0.00247	0.00254	CcSEcCtD
Tolazamide—Rash—Zidovudine—acquired immunodeficiency syndrome	0.00243	0.0025	CcSEcCtD
Tolazamide—Asthenia—Efavirenz—acquired immunodeficiency syndrome	0.00243	0.0025	CcSEcCtD
Tolazamide—Dyspepsia—Lamivudine—acquired immunodeficiency syndrome	0.00242	0.00249	CcSEcCtD
Tolazamide—Headache—Zidovudine—acquired immunodeficiency syndrome	0.00241	0.00249	CcSEcCtD
Tolazamide—KCNJ11—lymphoid tissue—acquired immunodeficiency syndrome	0.00241	0.102	CbGeAlD
Tolazamide—Pruritus—Efavirenz—acquired immunodeficiency syndrome	0.0024	0.00247	CcSEcCtD
Tolazamide—Urticaria—Ritonavir—acquired immunodeficiency syndrome	0.00238	0.00245	CcSEcCtD
Tolazamide—Feeling abnormal—Saquinavir—acquired immunodeficiency syndrome	0.00238	0.00245	CcSEcCtD
Tolazamide—Gastrointestinal disorder—Lamivudine—acquired immunodeficiency syndrome	0.00238	0.00244	CcSEcCtD
Tolazamide—Fatigue—Lamivudine—acquired immunodeficiency syndrome	0.00237	0.00244	CcSEcCtD
Tolazamide—Dizziness—Indinavir—acquired immunodeficiency syndrome	0.00237	0.00244	CcSEcCtD
Tolazamide—Asthenia—Delavirdine—acquired immunodeficiency syndrome	0.00232	0.00239	CcSEcCtD
Tolazamide—KCNJ1—brain—acquired immunodeficiency syndrome	0.00232	0.0978	CbGeAlD
Tolazamide—Pruritus—Delavirdine—acquired immunodeficiency syndrome	0.00229	0.00236	CcSEcCtD
Tolazamide—Urticaria—Saquinavir—acquired immunodeficiency syndrome	0.00229	0.00236	CcSEcCtD
Tolazamide—Nausea—Zidovudine—acquired immunodeficiency syndrome	0.00229	0.00236	CcSEcCtD
Tolazamide—Feeling abnormal—Lamivudine—acquired immunodeficiency syndrome	0.00227	0.00233	CcSEcCtD
Tolazamide—Rash—Indinavir—acquired immunodeficiency syndrome	0.00226	0.00233	CcSEcCtD
Tolazamide—Headache—Indinavir—acquired immunodeficiency syndrome	0.00225	0.00231	CcSEcCtD
Tolazamide—Dizziness—Efavirenz—acquired immunodeficiency syndrome	0.00224	0.00231	CcSEcCtD
Tolazamide—Urticaria—Lamivudine—acquired immunodeficiency syndrome	0.00219	0.00225	CcSEcCtD
Tolazamide—Asthenia—Ritonavir—acquired immunodeficiency syndrome	0.00215	0.00221	CcSEcCtD
Tolazamide—Dizziness—Delavirdine—acquired immunodeficiency syndrome	0.00214	0.00221	CcSEcCtD
Tolazamide—Rash—Efavirenz—acquired immunodeficiency syndrome	0.00214	0.0022	CcSEcCtD
Tolazamide—Nausea—Indinavir—acquired immunodeficiency syndrome	0.00213	0.00219	CcSEcCtD
Tolazamide—Headache—Efavirenz—acquired immunodeficiency syndrome	0.00212	0.00218	CcSEcCtD
Tolazamide—Pruritus—Ritonavir—acquired immunodeficiency syndrome	0.00212	0.00218	CcSEcCtD
Tolazamide—Asthenia—Saquinavir—acquired immunodeficiency syndrome	0.00207	0.00213	CcSEcCtD
Tolazamide—Rash—Delavirdine—acquired immunodeficiency syndrome	0.00204	0.0021	CcSEcCtD
Tolazamide—Pruritus—Saquinavir—acquired immunodeficiency syndrome	0.00204	0.0021	CcSEcCtD
Tolazamide—Headache—Delavirdine—acquired immunodeficiency syndrome	0.00203	0.00209	CcSEcCtD
Tolazamide—ABCC8—spinal cord—acquired immunodeficiency syndrome	0.00202	0.0849	CbGeAlD
Tolazamide—Nausea—Efavirenz—acquired immunodeficiency syndrome	0.00201	0.00207	CcSEcCtD
Tolazamide—Dizziness—Ritonavir—acquired immunodeficiency syndrome	0.00198	0.00204	CcSEcCtD
Tolazamide—Asthenia—Lamivudine—acquired immunodeficiency syndrome	0.00197	0.00203	CcSEcCtD
Tolazamide—Pruritus—Lamivudine—acquired immunodeficiency syndrome	0.00195	0.002	CcSEcCtD
Tolazamide—Nausea—Delavirdine—acquired immunodeficiency syndrome	0.00192	0.00198	CcSEcCtD
Tolazamide—Dizziness—Saquinavir—acquired immunodeficiency syndrome	0.00191	0.00196	CcSEcCtD
Tolazamide—Rash—Ritonavir—acquired immunodeficiency syndrome	0.00189	0.00194	CcSEcCtD
Tolazamide—Headache—Ritonavir—acquired immunodeficiency syndrome	0.00188	0.00193	CcSEcCtD
Tolazamide—KCNJ11—nervous system—acquired immunodeficiency syndrome	0.00184	0.0776	CbGeAlD
Tolazamide—Dizziness—Lamivudine—acquired immunodeficiency syndrome	0.00182	0.00187	CcSEcCtD
Tolazamide—Rash—Saquinavir—acquired immunodeficiency syndrome	0.00182	0.00187	CcSEcCtD
Tolazamide—Headache—Saquinavir—acquired immunodeficiency syndrome	0.00181	0.00186	CcSEcCtD
Tolazamide—Nausea—Ritonavir—acquired immunodeficiency syndrome	0.00178	0.00183	CcSEcCtD
Tolazamide—KCNJ11—central nervous system—acquired immunodeficiency syndrome	0.00177	0.0748	CbGeAlD
Tolazamide—Rash—Lamivudine—acquired immunodeficiency syndrome	0.00173	0.00179	CcSEcCtD
Tolazamide—Headache—Lamivudine—acquired immunodeficiency syndrome	0.00172	0.00177	CcSEcCtD
Tolazamide—Nausea—Saquinavir—acquired immunodeficiency syndrome	0.00171	0.00176	CcSEcCtD
Tolazamide—ABCC8—nervous system—acquired immunodeficiency syndrome	0.0017	0.0715	CbGeAlD
Tolazamide—ABCC8—central nervous system—acquired immunodeficiency syndrome	0.00163	0.0689	CbGeAlD
Tolazamide—Nausea—Lamivudine—acquired immunodeficiency syndrome	0.00163	0.00168	CcSEcCtD
Tolazamide—Glyburide—ALB—acquired immunodeficiency syndrome	0.0016	0.345	CrCbGaD
Tolazamide—KCNJ11—brain—acquired immunodeficiency syndrome	0.00141	0.0593	CbGeAlD
Tolazamide—KCNJ11—lymph node—acquired immunodeficiency syndrome	0.00136	0.0573	CbGeAlD
Tolazamide—ABCC8—brain—acquired immunodeficiency syndrome	0.0013	0.0547	CbGeAlD
